Application
L3MBTL2 Antibody (C-term) western blot analysis in Hela cell line lysates (35ug/lane).This demonstrates the L3MBTL2 antibody detected the L3MBTL2 protein (arrow).| Product Name | L3MBTL2 Antibody (C-term) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | L3MBTL2; Lethal(3)malignant brain tumor-like protein 2 |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WB |
| WB:1:100~500 |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Alternative Names | L3MBTL2 Lethal(3)malignant brain tumor-like protein 2 |
|---|---|
| Molecular Weight(MW) | 79110 Da |
| Function | Putative Polycomb group (PcG) protein. PcG proteins maintain the transcriptionally repressive state of genes, probably via a modification of chromatin, rendering it heritably changed in its expressibility. Its association with a chromatin-remodeling complex suggests that it may contribute to prevent expression of genes that trigger the cell into mitosis. Binds to monomethylated and dimethylated 'Lys-20' on histone H4. Binds histone H3 peptides that are monomethylated or dimethylated on 'Lys-4', 'Lys-9' or 'Lys-27' |
| Tissue Specificity | This L3MBTL2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 626-656 amino acids from the C-terminal region of human L3MBTL2. |
| Cellular Localization | Nucleus (Probable). |
| Entrez Gene | 83746 |
|---|---|
| Nucleotide Accession | NP_113676.2 |
Application
L3MBTL2 Antibody (C-term) western blot analysis in Hela cell line lysates (35ug/lane).This demonstrates the L3MBTL2 antibody detected the L3MBTL2 protein (arrow).| Application Notes | WB:1:100~500 |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
